Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01012881
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
CAU | (2S)-1-(9H-Carbazol-4-yloxy)-3- (isopropylamino)propan-2-ol | A | 2RH1 | 0.71 | |
YSH | 1-[3-CYANO-4-(NEOPENTYLOXY)PHENYL]- 1H-PYRAZOLE-4-CARBOXYLIC ACID | A,B | 1VDV | 0.7 | |
CIA | 6-BENZO[1,3]DIOXOL-5-YL-2-METHYL- 2,3,6,7,12,12A-HEXAHYDRO-PYRAZINO[1',2':1,6]PYRIDO[3,4- B]INDOLE-1,4-DIONE | A,B | 1UDU | 0.71 | |
CIA | 6-BENZO[1,3]DIOXOL-5-YL-2-METHYL- 2,3,6,7,12,12A-HEXAHYDRO-PYRAZINO[1',2':1,6]PYRIDO[3,4- B]INDOLE-1,4-DIONE | A | 1XOZ | 0.71 | |
SS4 | 3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2- .C.] PYRAZOLE | E | 2UZW | 0.7 | |
PO5 | (2S)-1-(dimethylamino)-3-(4-{[4- (6-morpholin-4-ylpyrazolo[1,5-b]pyridazin- 3-yl)pyrimidin-2-yl]amino}phenoxy)propan- 2-ol | A | 3EID | 0.71 | |
JK2 | 3-{5-[(2-fluorophenyl)amino]-1H- indazol-1-yl}-N-(3,4,5-trimethoxyphenyl)benzamide | A | 3FI3 | 0.82 | |
253 | 10,11-dimethoxy-4-methyldibenzo[c,f]- 2,7-naphthyridine-3,6-diamine | A | 2R7B | 0.72 | |
P13 | N-[2-(3-AMINOPROPOXY)-5-(1H-INDOL- 5-YL)BENZYL]-N-(2-PIPERAZIN-1-YLETHYL)AMINE | B | 1UTS | 0.7 | |
7PY | 7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)- 7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE | A,B | 2ETM | 0.71 | |
R04 | (2E)-N-ALLYL-4-{[3-(4-BROMOPHENYL)- 5-FLUORO-1-METHYL-1H-INDAZOL-6- YL]OXY}-N-METHYL-2-BUTEN-1-AMINE | A,B,C | 1H3A | 0.77 | |
T4B | A | 2NNQ | 0.71 | ||
3LG | (5-{[(2R)-1-(4-{3-[(2-METHOXYBENZYL)OXY]PROPOXY}PHENYL)- 6-OXOPIPERAZIN-2-YL]METHOXY}-1H- INDOL-1-YL)ACETIC ACID | B | 2G26 | 0.73 | |
HRM | 7-METHOXY-1-METHYL-9H-BETA-CARBOLINE | A | 2Z5X | 0.75 | |
HRM | 7-METHOXY-1-METHYL-9H-BETA-CARBOLINE | A | 2Z5Y | 0.75 | |
DTQ | 4-[3-HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE | A | 1DI8 | 0.71 | |
KIM | N~4~-methyl-N~4~-(3-methyl-1H-indazol- 6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine- 2,4-diamine | A | 3CJG | 0.77 | |
JK1 | 3-{4-[(phenylcarbamoyl)amino]-1H- pyrazol-1-yl}-N-(3,4,5-trimethoxyphenyl)benzamide | A | 3FI2 | 0.79 | |
4LG | METHYL (6-{[(2R)-1-(4-{3-[(2-METHOXYBENZYL)OXY]PROPOXY}PHENYL)- 6-OXOPIPERAZIN-2-YL]METHOXY}-1H- INDOL-1-YL)ACETATE | A,B | 2G27 | 0.75 | |
T2A | 5-methyl-7-phenyl-N-(3,4,5-trimethoxyphenyl)imidazo[5,1- f][1,2,4]triazin-2-amine | A,C | 3EOC | 0.74 | |
KS4 | 1-cyclobutyl-3-(3,4-dimethoxyphenyl)- 1H-pyrazolo[3,4-d]pyrimidin-4-amine | A,B | 3EN5 | 0.71 | |
43A | (3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)- 3-(1H-PYRROL-2-YLMETHYLENE)-1,3- DIHYDRO-2H-INDOL-2-ONE | A | 2AYP | 0.71 | |
GG2 | 1-(4-METHOXYPHENYL)-7-OXO-6-[4- (2-OXOPIPERIDIN-1-YL)PHENYL]-4,5,6,7- TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDINE- 3-CARBOXAMIDE | A | 2P16 | 0.75 | |
ET0 | 3-(5-methoxy-1H-indol-3-yl)propanoic acid | A,B | 3ET0 | 0.71 | |
BER | BERBERINE | A | 3D6Y | 0.7 | |
BER | BERBERINE | A,B,D,E | 1JUM | 0.7 | |
BER | BERBERINE | A,B,D,E | 3BTI | 0.7 | |
BER | BERBERINE | A | 2QVD | 0.7 | |
ASE | N-ACETYL SEROTONIN | A | 1NAS | 0.7 | |
IID | N-(1-ISOPROPYLPIPERIDIN-4-YL)-1- (3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE | A,B | 2BQ7 | 0.72 | |
ML2 | N-[2-(2-iodo-5-methoxy-1H-indol- 3-yl)ethyl]acetamide | A,B | 2QX9 | 0.73 | |
ML2 | N-[2-(2-iodo-5-methoxy-1H-indol- 3-yl)ethyl]acetamide | A,B | 2QX8 | 0.73 | |
SS5 | (2S)-1-[3-(CYCLOHEXYLMETHOXY)PHENYL]- 3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN- 3-YL]OXY}PROPAN-2-AMINE | A | 2UZV | 0.73 | |
LG0 | 1-(4-methoxyphenyl)-6-(4-(1-(pyrrolidin- 1-ylmethyl)cyclopropyl)phenyl)- 3-(trifluoromethyl)-5,6-dihydro- 1H-pyrazolo[3,4-c]pyridin-7(4H)- one | A | 3CS7 | 0.72 | |
4DE | 1-(4-METHOXYPHENYL)-3,5-DIMETHYL- 1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER | A,B | 1Y2D | 0.7 | |
SAV | N~4~-(3-methyl-1H-indazol-6-yl)- N~2~-(3,4,5-trimethoxyphenyl)pyrimidine- 2,4-diamine | A | 3CJF | 0.77 | |
2PY | (2S)-1-{[5-(1H-INDAZOL-5-YL)PYRIDIN- 3-YL]OXY}-3-[(7AS)-7AH-INDOL-3- YL]PROPAN-2-AMINE | E | 2OH0 | 0.71 | |
Q4A | N-(1-benzylpiperidin-4-yl)-6,7- dimethoxy-2-(4-methyl-1,4-diazepan- 1-yl)quinazolin-4-amine | A,B | 3FPD | 0.7 | |
L20 | (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3- METHYL-1H-INDAZOL-5-YL)PYRIDIN- 3-YL]OXY}PROPAN-2-AMINE | A | 2JDS | 0.72 | |
L20 | (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3- METHYL-1H-INDAZOL-5-YL)PYRIDIN- 3-YL]OXY}PROPAN-2-AMINE | A | 2JDR | 0.72 | |
L20 | (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3- METHYL-1H-INDAZOL-5-YL)PYRIDIN- 3-YL]OXY}PROPAN-2-AMINE | A | 2JDV | 0.72 | |
L20 | (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3- METHYL-1H-INDAZOL-5-YL)PYRIDIN- 3-YL]OXY}PROPAN-2-AMINE | E | 2UZU | 0.72 | |
R03 | ALLYL-{6-[3-(4-BROMO-PHENYL)-1- METHYL-1H-INDAZOL-6-YL]OXY}HEXYL)- N-METHYLAMINE | A,B,C | 1H39 | 0.78 | |
SS3 | (2S)-1-{[5-(3-METHYL-1H-INDAZOL- 5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN- 2-AMINE | A | 2UZT | 0.74 | |
EI1 | 3-ETHYL-2-(4-HYDROXYPHENYL)-2H- INDAZOL-5-OL | A,B | 2QAB | 0.71 | |
ML1 | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide | A,B | 2QX4 | 0.77 | |
ML1 | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide | A,B | 2QX6 | 0.77 | |
ML1 | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide | A,B | 2QWX | 0.77 | |
CKK | N-{[4-({5-[(4-aminopiperidin-1- yl)methyl]pyrrolo[2,1-f][1,2,4]triazin- 4-yl}oxy)-3-fluorophenyl]carbamoyl}- 2-(4-fluorophenyl)acetamide | A | 3C1X | 0.71 |